期刊文献+

淀粉基阴离子微球的制备 被引量:5

Study on synthesis of starch-based anion microspheres
下载PDF
导出
摘要 以可溶性淀粉为原料,N’N-亚甲基双丙烯酰胺(MBAA)及环氧氯丙烷(ECH)为交联剂,先在反向悬浮体系中采用两步交联法制备了中性淀粉微球,再用K3P3O9与中性淀粉微球反应制得淀粉基阴离子微球。以微球的平均粒径为指标,利用扫描电镜(SEM)和光透式粒度分析仪对产物进行了表征。结果表明,反应时间为2.5 h,淀粉溶液浓度为15%,油相与水相的体积比为3∶1,MBAA用量为0.4 g,乳化剂用量为1.0 g时,微球平均粒径分布较为均一,粒径在65μm以下的微球占95.5%,球形圆整,表面粗糙多孔,可用作药物载体和吸附剂。 The neutral starch microspheres were synthesized from soluble starch in the system of inverse suspension through two steps of bonding, using N, N'-methylenebisacrylamide and epichlorohydrin as crosslinker. The starch-based anion microspheres were made of neutral starch microspheres by the secondary reaction using K3 P3 09 as the crosslinking agent. The product was characterized by scanning electron microscopy (SEM) and granularity analyzer, the result showes that the concentration of starch solution is 15% ,the reaction time is 2.5 h ,oil and water phase volume ratio is 3 : 1 ,the use level of N,N' -methylenebisacrylamide is 0.4 g,the use levcl of emulsifying agent is 1.0 g. The average particle size of microspheres (≤65 μm) is 95.5%, and also are round, rough and porous which can be used as a kind of drug-carrier and adsorbents.
出处 《应用化工》 CAS CSCD 2007年第10期947-950,共4页 Applied Chemical Industry
基金 国家自然科学基金资助项目(50573046) 陕西省教育厅产业化培育项目(02JC05)
关键词 两步交联法 淀粉基阴离子微球 N'N-亚甲基双丙烯酰胺 环氧氯丙烷 two steps of cross bonding starch-based anion microspheres N, N'-methylenebisacrylamide epichlorohydrin
  • 相关文献

参考文献8

二级参考文献31

  • 1于九皋,田汝川,刘延奇.阴离子型淀粉微球的合成及性能研究[J].高等学校化学学报,1994,15(4):616-619. 被引量:35
  • 2修志龙,齐冬建,苏志国.纳米技术在药物制剂中的应用[J].高技术通讯,1996,6(9):56-59. 被引量:8
  • 3胡新 侯新朴.新型药物载体-淀粉微球[J].中国药学杂志,1995,30(2):69-69.
  • 4Nishioka Y, Kyotani S, Okamura M, et al. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin[J]. Chem Pharm Bull,1990,38(10):2871.
  • 5Hecquet B,Fournier C, Gdepadt, et al. Preparation and release linelics of microcapsule [J]. J Pharm Phaomac, 1984,36: 803-807.
  • 6Wang M, Sato H. Preparation and charaterization of Poly (lactic-co-glycolic acid) Microspheres for targeted delivery of a novel anticancer agent [J]. Taxol Chem Pharm Bull, 1996,44(10):1935-1940.
  • 7Vandelli MA, Forni F, Coppi G, et al. The effect of the cross-linking time period upon the drug release and the dynamic swelling of gelatin micropheres [J].Pharmazie, 1991,46:12.
  • 8Jalsenjaic I, Constantia FN, Colaikon and Nixon JR.The in vitro dissolution of phenlbar sodium from ethye cellulose microspheres[J]. J Pharm Phaomac, 1976,28:912-914.
  • 9Albin P, Markus A, Pelah Z. Slow-release indomethacin formulations based on polysaccharides:evaluation in vitro and in vivi in dogs [J]. J of controlled Release, 1994,29: 25.
  • 10Heya T, Okado H, Ogawa Y, et al. Factors influencing the profile of TPH release from copoly microspheres[J]. Int J Pharm, 1991,72:199.

共引文献76

同被引文献67

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部